Dr. Merilda Onyfel Blanco-Guzman, MD

Dr. Blanco-Guzman practices at Norton Hospital in Louisville, Kentucky, part of Norton Healthcare.

Dr. Blanco-Guzman's NPI, 1962684993, was assigned on November 30, 2007. Dr. Blanco-Guzman holds Kentucky license 52980.

Dr. Blanco-Guzman's primary practice is Norton Hospital, at 200 East Chestnut Street, Louisville, KY 40202 in Jefferson County. The practice phone is (502) 629-8000.

Dr. Blanco-Guzman's primary practice is Norton Hospital in Louisville, Kentucky, part of Norton Healthcare. The medical group on file is Norton Community Medical Associates. Dmand AI also links Dr. Blanco-Guzman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blanco-Guzman practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Blanco-Guzman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Blanco-Guzman's licenses on file in 2 states: Kentucky and Missouri.

CMS data shows 475 Medicare services from Dr. Blanco-Guzman across 4 procedure codes in 2024, for 177 Medicare patients. Medicare paid $44,415 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Blanco-Guzman in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blanco-Guzman's median patient age at 67, with 48% women.

In 2024, Dr. Blanco-Guzman wrote 113 Medicare Part D claims for 32 patients. 91% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $12,064 in total drug cost. In 2023, CMS named 470 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Blanco-Guzman for performance year 2024, reported as part of a group. Dr. Blanco-Guzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Blanco-Guzman, published from 2016 to 2021. The most frequent topics are Anti-Bacterial Agents, Heart-Assist Devices and Prosthesis-Related Infections. Dr. Blanco-Guzman has published most often in Transpl Infect Dis. Dr. Blanco-Guzman's most frequent co-authors are Erik R. Dubberke, MD, Justin Marinus Vader, MD and Xiaowen Wang, MD.

CMS Open Payments shows 51 general payments to Dr. Blanco-Guzman from 12 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 79% of the total. Gilead Sciences, Inc. paid the most, $544.